2
,5-Bis(morpholin-4-ylmethyl)-2,3-dihydrothieno[3,4-b][1,4]-
formaldehyde (37%, 2.0 eq.) with ice cooling. The solutions
were fed separately and simultaneously into glacial acetic acid
dioxin, 11c. 91%, mp 83–85 ЊC; δ (CDCl ) 2.49–2.52 (8H,
m, CH NCH ), 3.56 (4H, s, ArCH N), 3.69–3.73 (8H, m,
CH OCH ), 4.17 (4H, s, ArOCH ); δ (CDCl ) 52.9 (ArCH N),
3.0 (NCH ), 64.7 (ArOCH ), 66.9 (CH OCH ), 111.4 (C2/C5),
38.9 (C3/C4) (Found: C, 56.43; H, 7.18; N, 8.42. C H N O S
requires C, 56.45; H, 7.11; N, 8.23%); m/e 254 (M Ϫ
N(CH CH ) O).
H
3
3
Ϫ1
(0.3 cm mmol ) by means of a syringe pump with stirring.
After addition was complete, the solution was stirred for a
further 12 hours. The solvent was removed in vacuo to give
a dark oily residue. The work-up was similar to that applied
to the mono-Mannich bases. Purification by column chrom-
atography (alumina; light petroleum–EtOAc, 5 : 1) gave
the required Mannich base. Also isolated in these experiments
were a series of oligomeric Mannich bases containing three
thiophene moieties, 17, 19a–c and 23.
2
2
2
2
2
2
C
3
2
5
1
2 2 2 2
16
24
2
4
2
2 2
2
,5-Bis(piperidin-1-ylmethyl)-3,4-bis(2-ethoxyethoxy)thio-
phene, 12b. 35%, oil; δ (CDCl ) 1.23 (6H, t, J 6.93, OCH CH ),
.39 (4H, quintet, J 5.61, CH CH CH ), 1.57 (8H, quintet,
2 2 2
H
3
2
3
1
J 5.61, CH CH CH ), 2.43–2.46 (8H, m, CH NCH ), 3.56 (4H,
N,N-Bis[(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)methyl]-N-
methylamine, 16. 37%, mp 78–80 ЊC; δ (CDCl ) 2.29 (3H, s,
2
2
2
2
2
q, J 6.93, OCH CH ), 3.62 (4H, s, ArCH N), 3.64–3.69 (4H,
2
3
2
H
3
m, CH OEt), 4.11–4.15 (4H, m, ArOCH ); δ (CDCl ) 15.3
NCH ), 3.65 (4H, s, ArCH N), 4.18 (8H, s, ArOCH ), 6.25 (2H,
2
2
C
3
3
2
2
(
(
(
OCH CH ), 24.3 (CH CH CH ), 26.0 (CH CH CH ), 53.5
s, Ar-H); δ (CDCl ) 41.7 (NCH ), 51.0 (ArCH N), 64.7
C 3 3 2
2
3
2
2
2
2
2
2
ArCH N), 54.1 (NCH ), 66.6, 69.4 and 72.4 (OCH ), 121.8
(ArOCH ), 97.8 (C5), 114.6 (C2), 139.2 (C3), 141.2 (C4)
2
2
2
2
C2/C5), 145.7 (C3/C4) (Found: C, 63.51; H, 9.50; N, 6.05.
(Found: C, 53.20; H, 5.05; N, 4.06. C H NO S requires C,
15
17
4 2
ϩ
C H N O S requires C, 63.40; H, 9.31; N, 6.16%); m/e 454
53.08; H, 5.05; N, 4.13%); m/e 339 (M ).
2
4
42
2
4
ϩ
(
M ).
5
,7-Bis{[2,3-dihydrothieno[3,4-b][1,4]dioxin-5-ylmethyl-
methyl)amino]methyl}-2,3-dihydrothieno[3,4-b][1,4]dioxin, 17.
21%, oil; δ (CDCl ) 2.28 (6H, s, NCH ), 3.63, 3.64 (4H, s,
2
,5-Bis(morpholin-4-ylmethyl)-3,4-bis(2-ethoxyethoxy)thio-
(
phene, 12c. 24%, oil; δ (CDCl ) 1.23 (6H, t, J 6.93, OCH CH ),
.49–2.52 (8H, m, CH NCH ), 3.56 (4H, q, J 6.93, OCH CH ),
2 2 2 3
.61 (4H, s, ArCH N), 3.64–3.68 (4H, m, CH OEt), 3.69–3.73
8H, m, morpholino OCH ), 4.12–4.16 (4H, m, ArOCH );
δ (CDCl ) 15.3 (OCH CH ), 53.2 (NCH ), 53.6 (ArCH N),
6.6, 69.4 and 72.4 (OCH ), 67.0 (morpholino OCH ), 121.5
C2/C5), 146.1 (C3/C4) (Found: C, 57.80; H, 8.35; N, 5.99.
H
3
2
3
H
3
3
2
3
(
ArCH N), 4.16 (4H, s, ArOCH ), 4.17 (8H, s, ArOCH ), 6.23
(2H, s, Ar-H); δ (CDCl ) 41.5 (NCH ), 50.8, 50.9 (ArCH N),
C 3 3 2
64.6 (ArOCH ), 97.9 (C5Ј), 112.1 (C2/C5), 114.2 (C2Ј), 138.7
(C3/C4), 139.3 (C3Ј), 141.2 (C4Ј).
2
2
2
2
2
2
2
2
C
3
2
3
2
2
6
(
2
2
1
2
N ,N -Bis(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-ylmethyl)-
1
2
C H N O S requires C, 57.62; H, 8.35; N, 6.11%); m/e 458
2
2
38
2
6
N ,N -dimethylethane-1,2-diamine, 18a. 45%, mp 75.5–77.5 ЊC,
ϩ
(
M ).
δ (CDCl ) 2.29 (6H, s, N(CH )), 2.58 (4H, s, R NCH ), 3.63
H
3
3
2
2
(
4H, s, ArCH N), 4.17 (8H, s, ArOCH ), 6.25 (2H, s, Ar-H);
2
n
N,N-Dimethyl-N-{[7-(piperidin-1-ylmethyl)-2,3-dihydrothieno-
3,4-b][1,4]dioxin-5-yl]methyl}amine, 13. 54%, oil; δ (CDCl )
δ (CDCl ) 42.4 (NCH ), 52.0 (NCH ), 54.2 (ArCH N), 64.6
and 64.7 (ArOCH ), 97.7 (C5), 114.0 (C2), 139.3 (C3), 141.2
(C4) (Found: C, 54.62; H, 6.18; N, 6.77; C H N O S requires
C, 54.52; H, 6.10; N, 7.07%); m/e 396 (M ).
C
3
3
2
2
[
H
3
2
1
.39 (2H, quintet, J 5.61, CH CH CH ), 1.56 (4H, quintet,
2 2 2
18
24
2
4 2
J 5.61, CH CH CH ), 2.21 (6H, s, N(CH ) ), 2.41–2.44 (4H, m,
ϩ
2
2
2
3
2
CH NCH ), 3.51 (2H, s, ArCH N), 3.53 (2H, s, ArCH N),
2
2
2
2
4
.17 (4H, s, ArOCH ); δ (CDCl ) 24.1 (CH CH CH ), 25.9
1
3
2
C
3
2
2
2
N ,N -Bis(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-ylmethyl)-
(
CH CH CH ), 45.0 (NCH ), 53.0 (ArCH N), 53.2 (NCH ),
1
3
2
2
2
3
2
2
N ,N -dimethylpropane-1,3-diamine, 18b. 12%, oil, δ (CDCl )
1.73 (2H, quintet, J 7.59 Hz, CH CH CH ), 2.26 (6H, s,
N(CH )), 2.39–2.44 (4H, s, R NCH ), 3.58 (4H, s, ArCH N),
H
3
5
1
4.2 (ArCH N), 64.6, 64.7 (ArOCH ), 110.8, 112.5 (C2/C5),
38.5, 138.9 (C3/C4).
2
2
2 2 2
3
2
2
2
4
.16 (8H, s, ArOCH ), 6.22 (2H, s, Ar-H); δ (CDCl ) 25.2
n
C
3
N,N-Dimethyl-N-{[7-(morpholin-4-ylmethyl)-2,3-dihydro-
thieno[3,4-b][1,4]dioxin-5-yl]methyl}amine, 14. 74%, oil;
(
CH CH CH ), 42.2 (NCH ), 52.0 (NCH ), 54.2 (ArCH N),
2 2 2 3 2 2
6
1
4.3 and 64.6 (ArOCH ), 97.5 (C5), 114.5 (C2), 139.1 (C3),
2
δ (CDCl ) 2.21 (6H, s, N(CH ) ), 2.50–2.52 (4H, m,
H
3
3 2
41.2 (C4) (Found: C, 55.52; H, 6.58; N, 6.99. C H N O S
19
20
2
4 2
CH NCH ), 3.52 (2H, s, ArCH N), 3.53 (2H, s, ArCH N),
ϩ
2
2
2
2
requires C, 55.59; H, 6.38; N, 6.82%); m/e 410 (M ).
3
.68–3.72 (4H, m, CH OCH ), 4.17 (4H, s, ArOCH );
2
2
2
δ (CDCl ) 44.9 (NCH ), 53.0 (ArCH N), 53.8 (NCH ), 54.6
C
3
3
2
2
1
,4-Bis(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-ylmethyl)piper-
(
ArCH N), 64.6, 64.7 (ArOCH ), 67.2 (CH OCH ), 110.7,
2
2
2
2
azine, 18c. 22%, mp 158 ЊC (decomp.), δ (CDCl ) 2.55 (6H, s,
N(CH )), 2.55 (4H, s, R NCH ), 3.59 (4H, s, ArCH N), 4.17
8H, s, ArOCH ), 6.22 (2H, s, Ar-H); δ (CDCl ) 52.4 (NCH ),
2.5 (ArCH N), 64.6 (ArOCH ), 97.7 (C5), 113.6 (C2), 139.3
2 2
H
3
1
12.4 (C2/C5), 138.5, 138.9 (C3/C4).
-{[7-(Piperidin-1-ylmethyl)-2,3-dihydrothieno[3,4-b][1,4]-
3
2
2
2
(
5
(
n C 3 2
4
dioxin-5-yl]methyl}morpholine, 15. 91%, mp 64–66 ЊC;
C3), 141.2 (C4) (Found: C, 55.52; H, 6.58; N, 6.99.
δ (CDCl ) 1.40 (2H, quintet, J 5.61, CH CH CH ), 1.58 (4H,
H
3
2
2
2
C H N O S requires C, 55.59; H, 6.38; N, 6.82%); m/e 394
1
8
22
2
4 2
quintet, J 5.61, CH CH CH ), 2.42–2.45 (4H, m, piperidino
ϩ
2
2
2
(
M ).
CH NCH ), 2.49–2.52 (4H, m, morpholino CH NCH ),
2
2
2
2
3
.55 (2H, s, ArCH N), 3.56 (2H, s, ArCH N), 3.69–3.73 (4H,
2
2
5
,7-Bis{[{2-[(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-ylmethyl)-
m, CH OCH ), 4.17 (4H, s, ArOCH ); δ (CDCl ) 24.2
2
2
2
C
3
(
[
methyl)amino]ethyl}(methyl)amino]methyl}-2,3-dihydrothieno-
3,4-b][1,4]dioxin, 19a. 7%, oil; δ (CDCl ) 2.30 (6H, s,
N(CH )), 2.31 (6H, s, N(CH )), 2.62 (8H, m, NCH ), 3.61 (4H,
s, ArCH N), 3.62 (4H, s, ArCH N), 4.16 (8H, s, ArOCH ), 4.18
8H, s, ArOCH ), 6.24 (2H, s, Ar-H); δ (CDCl ) 42.3, 42.4
(
CH CH CH ), 26.0 (CH CH CH ), 52.9 (ArCH N), 53.0
2 2 2 2 2 2 2
H
3
(
NCH ), 53.2 (ArCH N), 53.9 (NCH ), 64.6, 64.7 (ArOCH ),
2 2 2 2
3
3
2
6
7.0 (CH OCH ), 110.8, 112.3 (C2/C5), 138.6, 138.9 (C3/C4)
2 2
2
2
2
(
Found: C, 60.12; H, 7.91; N, 8.04. C H N O S requires C,
17 26 2 3
(
(
2
C
3
6
0.33; H, 7.74; N, 8.28%); m/e 252 (M Ϫ N(CH CH ) O).
2 2 2
NCH ), 51.8, 52.0 (NCH ), 54.1, 54.2 (ArCH N), 64.6
3
2
2
(
1
ArOCH ), 97.7 (C Ј), 111.7 (C /C ), 114.0 (C Ј), 138.8 (C /C ),
2 5 2 5 2 3 4
Linking the thiophene moieties: synthesis of bis(thien-2-ylmethyl)
Mannich bases. General method
39.3 (C Ј), 141.2 (C Ј).
3 4
The thiophene moiety (2.0 eq.) was dissolved in glacial acetic
5,7-Bis{[{3-[(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-ylmethyl)-
3
Ϫ1
acid (1.25 cm mmol ). To an equal volume of glacial acetic
acid was added the secondary diamine or primary amine (40%
aqueous solution for methylamine) (1.0 eq.) and aqueous
(methyl)amino]propyl}(methyl)amino]methyl}-2,3-dihydrothieno-
[3,4-b][1,4]dioxin, 19b. 6%, oil; δ (CDCl ) 1.70–1.78 (4H, m,
H
3
CH CH CH ), 2.27 (12H, s, N(CH )), 2.41 (8H, m, NCH ), 3.61
2
2
2
3
2
2
602
J. Chem. Soc., Perkin Trans. 1, 2001, 2595–2603